Company Filing History:
5 out of 517 
2 out of 1,213 
1 out of 2,902 
Years Active: 2004-2018
Title: The Innovative Contributions of Steven Balk
Introduction
Steven Balk is a notable inventor based in Needham, MA (US), recognized for his significant contributions to the field of biomedical research. He holds a total of 5 patents, showcasing his dedication to advancing medical science and treatment methodologies.
Latest Patents
Among his latest patents, Balk has developed novel compounds related to Bone marrow on X chromosome kinase (BMX) inhibitors. This invention provides compounds of Formula (I) and their various forms, including pharmaceutically acceptable salts and derivatives. The methods and kits associated with these compounds aim to treat or prevent a wide range of diseases, including cancers and metabolic disorders such as type 2 diabetes. Another significant patent focuses on methods and compositions for treating metabolic disorders, highlighting the role of invariant NKT cells in reducing the incidence or severity of conditions like obesity and diabetes.
Career Highlights
Throughout his career, Steven Balk has worked with prestigious institutions such as Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute. His work in these organizations has contributed to groundbreaking research and innovative treatment options in the medical field.
Collaborations
Balk has collaborated with esteemed colleagues, including Mark A. Exley and Nathanael Schiander Gray, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Steven Balk's innovative work and patents reflect his commitment to improving healthcare through scientific advancements. His contributions continue to influence the treatment of various diseases, showcasing the importance of innovation in medicine.